Nutraveris

Category 'News'

Wednesday, August 27, 2014

Nutraveris Online updated with all the elements of the recently published French Law on Botanicals in Food Supplements

The French Law of 24 June 2014 establishing the list of authorized botanicals in food supplements and their conditions of use has been published the 17 July 2014 in the French Official Journal. It will be enforced the 1rst January 2015.

This law provides the list of botanicals contained in the food supplements in France authorized since 2006, according to the principle of the free movement of goods. The requirements are specific to each botanical:

  • Parts of plant
  • Levels of metabolites
  • Specific substances to monitor
  • Warnings and precautions of use aimed at populations at risk.

Any company commercializing a food supplement containing botanicals will have to ensure the availability of the following technical dossiers in case of authorities control:

  • For botanical preparations: a QUALITY dossier providing information on CHARACTERIZATION OF BOTANICAL PREPARATIONS (Annex II)
  • For botanical preparations which nature or conditions of use significantly differ from traditional use: a SAFETY dossier supporting the SAFETY OF BOTANICAL PREPARATIONS (Annex III).

Please do not hesitate to make an appointment with our experts and ask for a FREE demo of our database

Wednesday, October 16, 2013

Substantial Equivalence of BioDHA Algal Oil from Schizochytrium sp. : Nutraveris succeeded

Nutraveris constituted and submitted for evaluation an application on behalf of Bioplus Life Sciences Pvt. Ltd. for an opinion under Article 3.4. of the novel food Regulation (EC No. 258/97) on the substantial equivalence of BioDHA algal oil to DHA-rich algal oil which was authorised for the EU market to Martek Biosciences Corporation through Commission Decisions 2003/427/EC and 2009/778/EC.

Based on the information provided, the Food Safety Authority of Ireland (FSAI) is satisfied that BioDHA algal oil produced by Bioplus Life Sciences Pvt. Ltd. is substantially equivalent with respect to its composition, nutritional value, metabolism, intended use and level of undesirable substances to the Martek DHA-rich algal oil.

For any requirement about the novel food issue, ask our experts:
+33 2 96 76 54 87 or at contact@nutraveris.com

For more information and enquires on BioDHA please contact Mark Steinmann at Bioplus’ European Headquarters steinmann@bioplus.in or +49 1520 6408222.

Wednesday, June 5, 2013

EFSA call for data on 51 food additives

Under Regulation (EC) No 1333/2008, EFSA must re-evaluate by 2020 all authorized food additives.

For the re-evaluation of food additives for 2013 and 2014, EFSA has launched a new call for data asking Member States and other stakeholders for two types of data for 51 food additives in total: figures from industry on the amounts of these additives they report using in their products; and data derived from analyses indicating actual levels of these additives found in foods and drinks from national food authorities, research institutions, academia, food industry and other stakeholders.

The deadlines for the submission of data on usage level and/or concentration data in food and beverages intended for human consumption concerning the food additives listed in the table below is July and November 2013:

Thursday, March 7, 2013

Effects of chocolate on cardiovascular function in patients with heart failure

This double-blind, randomized placebo-controlled trial has compared the effect of a flavanol-rich chocolate to a control chocolate on endothelial and platelet function in 20 patients with heart failure. The effect of chocolate was assessed in the short-term (2h after ingestion) and long term (4 weeks). Flow-mediated vasodilatation has been increased in the flavanol-rich chocolate group in both short and long term. Conversely, endothelial-independent vasodilatation has not been affected by the supplementations. Platelet adhesion has been reduced 2h after flavanol-rich chocolate, but this effect was not observed after 4 weeks. Consequently, these results highlight cardiovascular beneficial effects of flavanol-rich chocolate.

Eur Heart J. 2012 Sep;33(17):2172-80
Cardiovascular effects of flavanol-rich chocolate in patients with heart failure.
Flammer AJ, Sudano I, Wolfrum M, Thomas R, Enseleit F, Périat D, Kaiser P, Hirt A, Hermann M, Serafini M, Lévêques A, Lüscher TF, Ruschitzka F, Noll G, Corti R

Tuesday, January 8, 2013

New EFSA’s statement on the safety of β-carotene use in heavy smokers

EFSA has published a new statement on the safety of β-carotene use in heavy smokers, following a request by the European Commission.
The Scientific Panel on Food Additives and Nutrient Sources added to Food (ANS) was asked to review existing data on the possible link between the ingestion of β-carotene and cancer enhancement in heavy smokers and to provide advice on a daily intake of β-carotene that does not give rise to concerns about adverse health effects in heavy smokers.

A meta-analysis of randomized controlled trials (RCT) investigating β-carotene supplementation and cancer risk (Druesne-Pecollo et al., 2010)
has been taken into account. Those data showed :
- absence of any protective effect associated with β-carotene supplementation with regard to primary cancer risk
- an increased risk of lung cancers in individuals supplemented with β-carotene at dose levels equal to or greater than 20 mg/day
- no increased lung cancer incidence in heavy smokers at supplemental dose levels of β-carotene varying from 6 – 15 mg/day for about 5 up to 7 years.

The Panel concluded that exposure to β-carotene from its use as food additive and as food supplement at a level below 15 mg/day do not give rise to concerns about adverse health effects in the general population, including heavy smokers.

New EFSA’s statement on the safety of β-carotene use in heavy smokers
EFSA Journal 2012;10(12):2953. [7 pp.]